EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Lynch Syndrome-associated Genomic Variants

Robert Botea, Madalina Piron-Dumitrascu, Tiberiu Augustin Georgescu, Camil Laurentiu Bohiltea, Silviu Cristian Voinea, Valentin Nicolae Varlas, Simona Raluca Iacoban, Nicolae Suciu

Journal of Gastrointestinal and Liver Diseases · 2024

DOI: 10.15403/jgld-5856 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, 2024. Verfasst von Robert Botea und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dept. of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, Bucharest; Dept. of Obstetrics and Gynecology, Alessandrescu-Ru…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Hereditary Nonpolyposis, Endometrial Neoplasms, Germ-Line Mutation, Exome Sequencing. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims: Lynch Syndrome, a hereditary disorder characterized by germline mutations in mismatch repair (MMR) genes, is a major contributor to colorectal cancers. It has also been identified in endometrial cancer. Despite the established role of MMR deficiency in tumorigenesis, the specific genomic alterations driving Lynch syndrome-associated endometrial cancer, and their overlap with colorectal cancer, remain incompletely understood. This study aims to fill this gap by performing a detailed comparative analysis of germline and somatic mutations in endometrial cancer within the context of Lynch syndrome.

Methods

We conducted whole exome sequencing on matched germline and somatic DNA from 13 patients diagnosed with Lynch syndrome-associated endometrial cancer. High-depth sequencing was performed, followed by rigorous bioinformatics analysis to identify and annotate variants, focusing on their potential pathogenicity and relevance to both endometrial and colorectal cancer.

Results

Our analysis revealed 1,118 germline and 14,051 somatic variants, with 493 variants common to both. Recurrent pathogenic mutations in MLH1, MSH2, and MSH6 were confirmed, highlighting their critical role in Lynch syndrome. Notably, frequent somatic mutations in the PIK3CA and PTEN genes were identified, implicating the PI3K/AKT/mTOR pathway as a key oncogenic driver in these cancers. Additionally, novel somatic mutations in genes related to the extracellular matrix such as FBN1 and SPARC were uncovered, suggesting a possible unique role in endometrial tumor progression.

Conclusions

This study provides new insights into the molecular basis of Lynch syndrome-associated endometrial cancer, emphasizing the overlap in oncogenic pathways with colorectal cancer. The discovery of shared and unique genetic mutations highlights the importance of developing combined treatment strategies and suggests that targeting these specific mutations could improve therapy for patients with Lynch syndrome-associated cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal Neoplasms, Hereditary NonpolyposisEndometrial NeoplasmsGerm-Line MutationExome SequencingHumansFemaleMiddle AgedGenetic Predisposition to DiseaseAgedMutS Homolog 2 ProteinMutationMutL Protein Homolog 1PTEN PhosphohydrolaseDNA Mismatch RepairClass I Phosphatidylinositol 3-KinasesAdultDNA-Binding Proteins

Substanzen

G-T mismatch-binding proteinMSH2 protein, humanMutS Homolog 2 ProteinMutL Protein Homolog 1MLH1 protein, humanPTEN PhosphohydrolasePTEN protein, humanClass I Phosphatidylinositol 3-KinasesPIK3CA protein, humanDNA-Binding Proteins

Autor:innen und Institutionen

  • Dept. of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, Bucharest; Dept. of Obstetrics and Gynecology, Alessandrescu-Rusescu National Institute of Mother and Child Health, Bucharest, Romani…
  • Dept. of Pathology, Carol Davila University of Medicine and Pharmacy, Bucharest; Dept. of Pathology, Alessandrescu-Rusescu National Institute of Mother and Child Health, Bucharest, Romania.
  • Dept. of Obstetrics and Gynecology, Alessandrescu-Rusescu National Institute of Mother and Child Health, Bucharest; Dept. of Medical Genetics, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Dept. of Oncological Surgery, Carol Davila University of Medicine and Pharmacy, Bucharest; Dept. of Oncological Surgery, Alexandru Trestioreanu Oncology Institute, Bucharest, Romania. silviu.voinea@umfcd.ro.
  • Dept. of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, Bucharest; Dept. of Obstetrics and Gynecology, Filantropia Obstetrics and Gynecology Clinical Hospital, Bucharest, Romania.
  • Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. simona@iacoban.ro.

Zitieren

APA

Botea, R., Piron-Dumitrascu, M., Georgescu, T. A., Bohiltea, C. L., Voinea, S. C., Varlas, V. N., Iacoban, S. R., & Suciu, N. (2024). Lynch Syndrome-associated Genomic Variants. Journal of Gastrointestinal and Liver Diseases. https://doi.org/10.15403/jgld-5856

Vancouver

Botea R, Piron-Dumitrascu M, Georgescu TA, Bohiltea CL, Voinea SC, Varlas VN, et al. Lynch Syndrome-associated Genomic Variants. Journal of Gastrointestinal and Liver Diseases. 2024. doi:10.15403/jgld-5856

BibTeX
@article{Botea2024,
  author = {Botea, Robert and Piron-Dumitrascu, Madalina and Georgescu, Tiberiu Augustin and Bohiltea, Camil Laurentiu and Voinea, Silviu Cristian and Varlas, Valentin Nicolae and Iacoban, Simona Raluca and Suciu, Nicolae},
  title = {Lynch Syndrome-associated Genomic Variants},
  journal = {Journal of Gastrointestinal and Liver Diseases},
  year = {2024},
  doi = {10.15403/jgld-5856}
}
Kostenlos starten →